Matches in Nanopublications for { ?s ?p "DDI between Tamsulosin and Fosamprenavir - Fosamprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Fosamprenavir is initiated, discontinued, or dose changed. [drugbank_resource:DB00706_DB01319]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00706_DB01319 label "DDI between Tamsulosin and Fosamprenavir - Fosamprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Fosamprenavir is initiated, discontinued, or dose changed. [drugbank_resource:DB00706_DB01319]" assertion.